10th PMWC 2016 Personalized Medicine World Conference
COMPUTER HISTORY MUSEUM
1401 N SHORELINE BLVD MOUNTAIN VIEW, CA 94043 (650) 810-1010
MOUNTAIN VIEW, CA, USA
http://2016sv.pmwcintl.com/
PMWC ADDRESSES A NEED
The Personalized Medicine World Conference (PMWC) is an independent and established conference that attracts recognized authorities and experts across healthcare and biotechnology sectors. The Conference showcases practical content that helps close the knowledge gap between different sectors, thereby catalyzing cross-functional collaboration to further adoption of personalized medicine in the clinic.


PMWC OVERVIEW
DETAILS 
ABOUT 
• Started in 2009 in Silicon Valley
• Satellite conferences in Israel & UK
Established & Growing

 
• Stanford Health Care
• Oracle Health Sciences
• UCSF
Leading Co-hosts

 
• Multidisciplinary
• Executive-level decision makers
• Many international attendees
Attendees and KOL’s
• State-of-the-art and forward-looking focus
• Open discussion of PM’s obstacles and challenges
• Innovative technologies and business models


PARKING
There are only 500-600 parking spaces at the Computer History Museum, but thanks to Microsoft, we can accommodate attendee overflow with additional parking at Microsoft Campus. A free shuttle service between the CHM and the Microsoft lot will be available from 7:30am to 5:30pm.

TRANSPORTATION
Shuttles and taxis are available from both airports with rates of $80-$90 from SFO and $40-$50 from SJC.

Yellow Cab Taxi Airport Ride (top-rated on Yelp)
$80 SFO to Mountain View
$40 SJC to Mountain View
Emails: garylimo4u@gmail.com or yellowtaxirides@gmail.com
Phones: 408-412-3100, 408-799-4666, 408-412-3200, 408-214-6969

Schedule of Presentations:

Sunday, January 24, 2016
18:30:00 Luminary and Pioneer Award Reception honoring Roger Perlmutter, Laura Esserman, Irv Weissman and Ralph Snyderman. Different venue with separate registration (req.); send inquiries to luminary@pmwcintl.com (space is limited)
Monday, January 25, 2016
07:00:00 TRACK 1 | Registration, Breakfast and Networking
07:50:00 TRACK 1 | Opening words by program chair Atul J. Butte
07:55:00 TRACK 1 | Opening words by co-host Euan A. Ashley
08:05:00 TRACK 1 | Opening words by co-host SAM HAWGOOD
08:15:00 TRACK 1 | Fireside Chat Robert M. Califf, Ralph Snyderman
08:20:00 TRACK 1 | Advancing Wellness with Preventative and PM
08:45:00 TRACK 1 | Launching a New Sector - Scientific Wellness Ralph Snyderman, CLAYTON LEWIS
08:55:00 TRACK 2 | NGS And Clinical Interplay
09:00:00 TRACK 2 | Panel RICHARD KLAUSNER, KLAUS LINDPAINTNER, Jonas Korlach, PETER PAUL YU, ALLISON BALLMER
09:15:00 TRACK 1 | Managing Health Using Personal Omics Profiling Mike Snyder
09:30:00 TRACK 1 | New Models for Genomics-based Health
09:45:00 TRACK 1 | Honoree Keynote ROGER PERLMUTTER
09:45:00 TRACK 2 | Single Molecule Sequencing with Microdroplets CAMERON FRAYLING
10:00:00 TRACK 1 | Break, Exhibition & Networking
10:00:00 TRACK 2 | Break, Exhibition & Networking
10:00:00 TRACK 4 | Break, Exhibition & Networking
10:05:00 TRACK 2 | Practicing Pathologists in Personalized Medicine
10:25:00 TRACK 1 | Cancer Diagnostics
10:25:00 TRACK 4 | Company Competition Semi-finals:
10:30:00 TRACK 4 | NIH Expands I-Corps for SBIR Grantees ANDREW KURTZ
10:30:00 TRACK 1 | Opening by session chair ANN KAPOUN
10:30:00 TRACK 2 | Opening by session chair Bill Lundberg
10:45:00 TRACK 4 | Aldatu Biosciences
10:45:00 TRACK 2 | Precision Diagnosis of Infections by Metagenomic Sequencing Steve Miller
10:45:00 TRACK 1 | TBA Laura Esserman
11:00:00 TRACK 4 | Atomo Diagnostics
11:00:00 TRACK 2 | Novel Actionable Mutations in Cutaneous T-Cell Lymphoma KOJO ELENITOBA-JOHNSON
11:00:00 TRACK 1 | Democratizing Oncology Precision Medicine with NGS KLAUS LINDPAINTNER
11:10:00 TRACK 3 | Neuro Dx
11:15:00 TRACK 4 | Episona
11:15:00 TRACK 3 | CNSDose – Genetically Guided Antidepressants AJEET B. SINGH
11:15:00 TRACK 1 | Powering Precision Oncology with 3D Biology BRAD GRAY
11:15:00 TRACK 2 | Pathology Radiology Integration: Emerging Tools for Converging Diagnostics ALEXANDER JUDKINS
11:25:00 TRACK 1 | Cancer Diagnostics- Cont
11:25:00 TRACK 2 | PM in Organ Transplantation
11:30:00 TRACK 3 | Molecular Mimicry and Infections Causing CNS Disorders
11:30:00 TRACK 1 | Clonality & MRD Testing in Clinical Practice Jeffrey S. Miller
11:30:00 TRACK 4 | Gliimpse
11:30:00 TRACK 2 | Personalized Medicine in Organ Transplantation John J. Sninsky
11:40:00 TRACK 3 | Biomarkers: Technologies
11:45:00 TRACK 1 | Immunosequencing in the Service of Immune-Oncology ILAN KIRSCH
11:45:00 TRACK 4 | HealthMyne
11:45:00 TRACK 3 | Personalization of Tumor Therapy Using Biophysical Markers BIANA GODIN
11:45:00 TRACK 2 | Clinical use of Genomic Biomarkers in Transplantation
12:00:00 TRACK 3 | BCL2 Variation Determines Chemotherapy Response SOL EFRONI
12:00:00 TRACK 2 | The SORT Assay for Diagnosis of Organ Transplant Rejection MINNIE SARWAL
12:00:00 TRACK 1 | Raghu Kalluri
12:00:00 TRACK 4 | ImaginAb
12:15:00 TRACK 3 | Lunch, Exhibition & Networking
12:15:00 TRACK 4 | Lunch, Exhibition & Networking
12:15:00 TRACK 2 | Lunch, Exhibition & Networking
12:15:00 Lunch, Exhibition & Networking
12:20:00 TRACK 3 | Liquid Biopsy, Technological Advancements
12:55:00 TRACK 2 | From Biomarkers to Clinical Diagnostics
12:55:00 TRACK 4 | Company Competition Semi-finals - Cont
13:00:00 TRACK 2 | Omics, Outcomes and Ouchies: Relevant Measurements ANDREAS KOGELNIK
13:00:00 TRACK 3 | Droplet Digital PCR: Ally in the Care of Cancer and Other Diseases GEORGE KARLIN-NEUMANN
13:00:00 TRACK 4 | Inivata
13:10:00 TRACK 1 | Cancer Diagnostics- Cont.
13:15:00 TRACK 2 | Where Have All the Biomarkers Gone? Anna D Barker
13:15:00 TRACK 1 | Cancer Diagnostics JOHN WEST
13:15:00 TRACK 3 | Genomic Cancer Diagnostic in a Community Hospital
13:15:00 TRACK 4 | Mindera
13:30:00 TRACK 2 | Diagnostic Potential of Non-coding RNA in Cancer Timothy J Triche
13:30:00 TRACK 4 | Veritas Genetics
13:30:00 TRACK 3 | The Use of Multiplexed ICE COLD-PCR Coupled to Multiple Downstream Analysis Platforms Katherine Richardson
13:30:00 TRACK 1 | Clinical Interpretation Equals Patient-specific Analysis CHRISTINE M. COURNOYER
13:45:00 TRACK 2 | Panel
13:45:00 TRACK 4 | Vortex Biosciences
13:45:00 TRACK 1 | Scaling NGS Test Interpretation and Reporting In Oncology
13:45:00 TRACK 3 | Detection of SNVs and CNVs in ctDNA using Massively-Multiplexed PCR Matthew Phillips
13:50:00 TRACK 2 | Proteomics and Personalized Medicine: Ongoing Partnership
13:55:00 TRACK 3 | Liquid Biospy, Clinical Testing Applications
13:55:00 TRACK 1 | Impact of Patient Data Access on Oncology Precision Medicine
14:00:00 TRACK 1 | Opening by session chair MARTIN NALEY
14:00:00 TRACK 3 | Liquid Biopsies in the Management of Cancer
14:00:00 TRACK 2 | Opening by session chair
14:00:00 TRACK 4 | XCell Biosciences
14:05:00 TRACK 1 | Panel ALICIA CORNISH, LISA HOLLAND, JAMIE KECK, MICHAEL VINEGRA, BRIAN WRIGHT
14:15:00 TRACK 2 | HiD Cell Barcoding & Imaging Garry P Nolan
14:15:00 TRACK 3 | cfDNA or CTCs: Which is Better? NICHOLAS DRACOPOLI
14:25:00 TRACK 4 | Investments in PM: What to Consider
14:30:00 TRACK 3 | Completing the Answer in Oncology
14:30:00 TRACK 4 | Seed Round to Exit in 18 Months: Lessons Learned from Carmenta Bioscience Matthew Cooper
14:30:00 TRACK 2 | Precision Medicine: One Scientist’s Perspective JACOB KENNEDY
14:45:00 TRACK 4 | Capital Markets & M&A Trends BRIAN BOCK
14:45:00 TRACK 2 | Panel
14:45:00 TRACK 3 | CTCs: Capturing, Cultivation and Molecular Analysis THOMAS KRAHN
15:00:00 Break, Exhibition & Networking
15:00:00 TRACK 3 | Break, Exhibition & Networking
15:00:00 TRACK 4 | Break, Exhibition & Networking
15:00:00 TRACK 2 | Break, Exhibition & Networking
15:05:00 TRACK 2 | Emerging Company Competition Finals
15:25:00 TRACK 3 | Liquid Biospy, Clinical Testing Applications- Cont
15:25:00 TRACK 4 | PM and Diagnostics Beyond the USA
15:25:00 TRACK 1 | Clinical Implementation of Precision Medicine Programs
15:30:00 TRACK 1 | PANEL SUZANNE BELINSON, THOMAS D. BROWN, DAX KURBEGOV, Lincoln D. Nadauld, JONATHAN HIRSCH
15:30:00 TRACK 2 | Opening words by session chair SHELDON M. SCHUSTER
15:30:00 TRACK 4 | Personalised Medicine: A Priority for Europe ANDERS COLVER
15:35:00 TRACK 3 | Exosomal RNA-based Liquid Biopsies: Why cfDNA Alone is Not Sufficient for Non-invasive Genotyping
15:45:00 TRACK 4 | EPEMED Mara Aspinall
15:45:00 TRACK 3 | CRISTIAN IONESCU-ZANETTI
16:00:00 TRACK 3 | Closing
16:00:00 TRACK 4 | Closing
16:10:00 TRACK 1 | Healthcare Information and Management Systems
16:15:00 TRACK 1 | Learning & Ranking of Treatment Options in Precision Oncology
16:30:00 TRACK 2 | Closing
16:30:00 TRACK 1 | Not Just Noise: Transforming Big Data into Smart Data BRADY DAVIS
16:45:00 TRACK 1 | Fireside Chat BONNIE H. ANDERSON
17:00:00 TRACK 1 | Closing
Tuesday, January 26, 2016
07:00:00 TRACK 1 | Registration, Breakfast and Networking
07:30:00 TRACK 1 | More Shades of Gray? FDA Compliance After Pathway and Theranos SHEILA D. WALCOFF
07:45:00 TRACK 1 | Precision Oncology -- Challenges, Opportunities, Models KATHY GIUSTI
07:55:00 TRACK 2 | Diagnosis & Management of Rare Disease
07:55:00 TRACK 1 | Why Biobanking?
08:00:00 TRACK 1 | Good Biobanking Is Hard JOE VOCKLEY
08:00:00 TRACK 2 | Opening words by session chair PATRICE MILOS
08:05:00 TRACK 1 | Kaiser Permanente: HMO-based Bio-banking Model CATHERINE SCHAEFER
08:15:00 TRACK 2 | Speaking of Rare Diseases: Transforming the Paradigm SHARON TERRY
08:30:00 TRACK 2 | A Holistic Approach to Research and Clinical Care in Pediatric Rare Disease
08:30:00 TRACK 1 | UK Biobank: Resource for Genetic-epidemiological Research RORY COLLINS
08:40:00 TRACK 3 | Podium Present. Genome Data Analysis & Mgmt.
08:40:00 TRACK 1 | Knowledge Within Healthcare Data For PM
08:40:00 TRACK 4 | Podium Present. Next Generation Tools
08:45:00 TRACK 1 | Multimodal Data Analytics Accelerate Actionable Insights
08:45:00 TRACK 2 | Unique Challenges to Discover and Develop Novel Therapeutics Albert B. Seymour
08:45:00 TRACK 3 | Omics-based (CDx)-drug-(Rx) Solution MOHAMOOD ADHIL
08:45:00 TRACK 4 | Towards Predictive Biology with Extreme Scale Computing FRED STREITZ
08:55:00 TRACK 2 | Biomarkers for Autoimmune Disease
08:55:00 TRACK 1 | Data-Driven Rx & Dx
09:00:00 TRACK 3 | Informatics & Instruments Consolidation: Positive or Negative? MICHAEL BALL
09:00:00 TRACK 2 | Opening words by session chair ERIC SASSO
09:00:00 TRACK 4 | Developing High Accuracy Nanopore Sequencer for $100 Genome BHARAH TAKULAPALLI
09:00:00 TRACK 1 | Opening words by session chair Atul J. Butte
09:15:00 TRACK 3 | Collecting Genomic Data - Is a New Ethical Approach Required? INGRID SLADE
09:15:00 TRACK 2 | Disease Heterogeneity and Drug Response in Rheumatoid Arthritis MICHAEL TOWNSEND
09:15:00 TRACK 1 | Turning Big Data into Smart Data Asim Siddiqui
09:15:00 TRACK 4 | Miniaturized Instrumentation to Enable Personalized Medicine PETER PEUMANS
09:25:00 TRACK 4 | Pathogen Dx
09:30:00 TRACK 2 | Sequencing Antibody Repertoires in RA WILLIAM ROBINSON
09:30:00 TRACK 4 | Infectious Disease Diagnosis Using SeptiCyte® Gene Signature LEO McHUGH
09:30:00 TRACK 3 | DRAGEN Hybrid Cloud: The Turnkey Genomics Compute and Storage Solution PIETER VAN ROOYEN
09:30:00 TRACK 1 | Molecular Information - Catalyst for Precision Oncology MATT FRANKLIN
09:45:00 TRACK 4 | CHARLES CHIU
09:45:00 TRACK 3 | TGex: NGS Analysis Made Simple DVIR DAHARY
09:45:00 TRACK 1 | Artificial Intelligence in Drug Development: Case Studies
10:00:00 TRACK 1 | Break, Exhibition & Networking
10:00:00 TRACK 4 | Break, Exhibition & Networking
10:00:00 TRACK 2 | Break, Exhibition & Networking
10:00:00 TRACK 3 | Break, Exhibition & Networking
10:25:00 TRACK 1 | Data Solutions in Clinical Genomics
10:25:00 TRACK 3 | Synthetic Biology's Rise in PM
10:25:00 TRACK 2 | Noninvasive Liquid Biopsies for Cancer Patients
10:30:00 TRACK 2 | Opening words by session chair Walter H. Koch
10:30:00 TRACK 3 | 2015 Synthetic Biology Roundup
10:30:00 TRACK 1 | Opening words by session chair DAVID HAUSSLER
10:30:00 TRACK 4 | Opening words by session chair Ketan Paranjape
10:40:00 TRACK 1 | Panel JONATHAN SHELDON, CARLOS BUSTAMANTE, DAVID HAUSSLER
10:45:00 TRACK 2 | Liquid Biopsy Approaches for Characterizing Cancer Genomes Luis A. Diaz
10:45:00 TRACK 3 | Organs-On-Chips for Advancing Precision Medicine
10:45:00 TRACK 2 | Panel
10:45:00 TRACK 4 | PATRICIA KOVATCH
11:00:00 TRACK 4 | TIM CUTTS
11:00:00 TRACK 2 | Analysis of Circulating Tumor DNA for Personalized Cancer Detection and Monitoring Maximilian Diehn
11:00:00 TRACK 3 | Personalized Medicine Using iPSCs and Organs-on-Chips Clive Svendsen
11:15:00 TRACK 2 | Panel
11:15:00 TRACK 3 | Rewriting DNA Synthesis
11:15:00 TRACK 4 | CHRIS DWAN
11:25:00 TRACK 3 | CRISPR Genome Editing
11:25:00 TRACK 1 | Generating Data-Driven Insight in Personalized Medicine Programs
11:30:00 TRACK 3 | Gene Correction with CRISPR-Cas9 JACOB CORN
11:30:00 TRACK 2 | Commercial Applications in Liquid Biopsy
11:30:00 TRACK 4 | Engaging a Country for Precision Medicine MARK BEGGS
11:30:00 TRACK 1 | Panel Mathias Ehrich, TYLER WISH, AARON BLACK
11:35:00 TRACK 2 | Protein-complexes on Exosomes Enable Liquid Biopsy DAVID SPETZLER
11:45:00 TRACK 4 | John S Witte
11:45:00 TRACK 2 | Why Technology Matters for Commercialization and Adoption ROOPOM BANERJEE
11:45:00 TRACK 1 | Panel Continues
11:50:00 TRACK 3 | ANDREW MAY
11:55:00 TRACK 3 | CAR-T
12:00:00 TRACK 3 | MicAbody™ Proteins Engage NK- and T-Cells DAVID MARTIN
12:00:00 TRACK 4 | Lunch, Exhibition & Networking
12:00:00 TRACK 2 | Liquid Biopsy in Immunotherapy and Beyond
12:15:00 TRACK 1 | Lunch, Exhibition & Networking
12:15:00 TRACK 3 | Lunch, Exhibition & Networking
12:15:00 TRACK 2 | Lunch, Exhibition & Networking
12:55:00 TRACK 1 | Generating Data-Driven Insight- Cont.
12:55:00 TRACK 4 | Clinically Useful Genome Interpretation
12:55:00 TRACK 2 | Liquid Biopsy – Using the Right Tool for the Right Job
13:00:00 TRACK 4 | Germline Testing for Hereditary Cancer
13:00:00 TRACK 1 | Learning As We Go: Updating Biomedical Knowledge From Data JANUSZ DUTKOWSKI
13:00:00 TRACK 2 | Liquid Biopsy – Using the Right Tool for the Right Job
13:00:00 TRACK 3 | Whole Genome? The Future of High-Quality, De Novo Human Genomes Jonas Korlach
13:10:00 TRACK 1 | Genome: Silos, Hacking Privacy, Collaboration
13:15:00 TRACK 1 | Opening words by session chair SOMALEE DATTA
13:15:00 TRACK 2 | Cancer’s Tweet: 160bp Snapshots into Cancer’s Hidden Evolution HELMY ELTOUKHY
13:15:00 TRACK 4 | Why We Should Classify Genotypes, Not Variants NATHAN PEARSON
13:25:00 TRACK 3 | Cancer Dx
13:30:00 TRACK 2 | Revolutionizing Cancer Care with Urine ctDNA
13:30:00 TRACK 1 | The VA Million Veterans Program PHILIP TSAO
13:30:00 TRACK 3 | Integrated Genomic Platform for Companion Diagnostics ANNE-RENEE HARTMAN
13:45:00 TRACK 1 | Access vs Privacy: A False Dichotomy WILLIAM KNOX CAREY
13:45:00 TRACK 3 | E. Rowinsky
13:45:00 TRACK 2 | Panel
13:55:00 TRACK 4 | Unlocking Data to Advance PM
14:00:00 TRACK 4 | The Portable Cancer Model, Merging EMR with Genomic Data
14:00:00 TRACK 3 | Genomic Tumor Proflling – Advancing Beyond Gene Mutations HAWAZIN FARUKI
14:00:00 TRACK 1 | Panel
14:00:00 TRACK 2 | CtDNA Guides Therapeutic Decisions for Cancer Patients. FACT or FICTION? PHIL STEPHENS
14:10:00 TRACK 1 | Patient Experience
14:15:00 TRACK 1 | Opening words by session chair
14:15:00 TRACK 3 | Functional Profiling to Guide Cancer Drug Development and Treatment Selection JERRY PARROTT
14:15:00 TRACK 4 | Precise Medicines from Data
14:15:00 TRACK 2 | Liquid biopsy in One Clinical’s Patient Trial Paradigm JEAN-FRANCOIS LAES
14:25:00 TRACK 2 | Genetics Informed Personalized Immunotherapy
14:30:00 TRACK 2 | Opening words by session chair
14:30:00 TRACK 1 | Panel RICHARD SCHILSKY, MAURIE MARKMAN
14:30:00 TRACK 3 | Comprehensive Tumor Profiling: Its more than Genes
14:30:00 TRACK 4 | Collaborative Cancer Care: Unlocking Data
14:45:00 TRACK 4 | Panel
14:45:00 TRACK 2 | Genomics Enhances Clinical Immuno-oncology Trials Patrice Hugo
14:45:00 TRACK 3 | NGS Presents New Quality Control Challenges Russell Garlick
14:45:00 TRACK 1 | Panel Continues
15:00:00 TRACK 1 | Panel Continues
15:00:00 TRACK 4 | Break, Exhibition & Networking
15:00:00 TRACK 2 | Panel
15:00:00 TRACK 3 | Break, Exhibition & Networking
15:15:00 TRACK 2 | Break, Exhibition & Networking
15:15:00 TRACK 1 | Break, Exhibition & Networking
15:25:00 TRACK 1 | Reimbursement Challenges and Solutions
15:30:00 TRACK 2 | Panel
15:30:00 TRACK 1 | Opening words by session chair RINA WOLF
15:30:00 TRACK 3 | Closing
15:40:00 TRACK 2 | Metabolomics and Its Role in the Movement Towards PM
15:45:00 TRACK 1 | MolDX 2016: Updates and Lessons Learned
15:45:00 TRACK 2 | Opening words by session chair JOHN RYALS
15:55:00 TRACK 4 | Petabyte Scale Genomics: Using Big Metal to Study Big Cohorts
16:00:00 TRACK 4 | FRANK AUSTIN NOTHAFT
16:00:00 TRACK 2 | Metabolomic Profiling - Leading Towards the Elucidation of Disease ANDREAS KOGELNIK
16:00:00 TRACK 1 | Different Perspectives, Common Goals: Getting Stakeholders Aligned
16:15:00 TRACK 2 | A Patient Journey DEAUNNE DENMARK
16:15:00 TRACK 4 | CUIPING PAN
16:15:00 TRACK 1 | Panel
16:25:00 TRACK 1 | Stem Cell Research
16:30:00 TRACK 4 | MIKE LIN
16:30:00 TRACK 1 | Normal and Cancer Stem Cells: Biology and Translation
16:30:00 TRACK 2 | Panel
16:45:00 TRACK 2 | Closing
16:45:00 TRACK 4 | URI LASERSON
16:50:00 TRACK 1 | Closing
17:00:00 TRACK 4 | Closing
Wednesday, January 27, 2016
07:00:00 TRACK 1 | Registration, Breakfast and Networking
07:55:00 TRACK 1 | The Give and Take Between Government & Personalized Medicine
08:00:00 TRACK 1 | The President’s Precision Medicine Initiative® KATHY L. HUDSON
08:15:00 TRACK 2 | The Role of Algorithms in Clinical Diagnostics Mara Aspinall
08:15:00 TRACK 1 | Personalized Medicine – Creating Value for Patients Atul J. Butte
08:25:00 TRACK 2 | Large-scale Genomics Projects
08:30:00 TRACK 2 | Geisinger’s Precision Health Initiative DAVID LEDBETTER
08:30:00 TRACK 1 | TBA
08:45:00 TRACK 1 | Precision Medicine: Beyond The Inflection Point KEITH YAMAMOTO
08:45:00 TRACK 2 | Using Genetics to Improve Healthcare PETER DONNELLY
08:55:00 TRACK 1 | Patient-centered Drug Development
09:00:00 TRACK 2 | Genomics in the Next Five Years ANDREW CARROLL
09:00:00 TRACK 1 | Clinical Innovation Using Outcomes Data DAVID JACKSON
09:15:00 TRACK 1 | Re-Engineering The US Clinical Trials System TIMOTHY YEATMAN
09:15:00 TRACK 2 | Delivering Precision Medicine Worldwide Today
09:30:00 TRACK 2 | Genomic Data, Migration Patterns & Disease Catherine A Ball
09:30:00 TRACK 1 | Promoting Pharmacogenomics to the Public Alan H.B. Wu
09:40:00 TRACK 3 | Genomics Offered As-a-Service
09:40:00 TRACK 2 | Panel
09:45:00 TRACK 3 | Responsible Genetic Testing at Color Genomics
09:45:00 TRACK 1 | Panel
10:00:00 TRACK 1 | Break, Exhibition & Networking
10:00:00 TRACK 2 | Break, Exhibition & Networking
10:00:00 TRACK 3 | Break, Exhibition & Networking
10:25:00 TRACK 3 | Precision Medicine in the Clinical Workflow
10:25:00 TRACK 1 | New Drug Discovery in Oncology: Faster, Cheaper, Better
10:25:00 TRACK 2 | Large Scale Sequencing and Analysis
10:30:00 TRACK 3 | Precision Medicine in the Clinical Workflow
10:30:00 TRACK 2 | Opening words by session chair DAVID GLAZER
10:40:00 TRACK 1 | Opening words by session chair George W. Sledge
10:45:00 TRACK 3 | Efficiency and Transparency in Genetic Diagnostics MARK HARRIS
10:45:00 TRACK 1 | Expediting Development of Oncology Drugs GIDEON MICHAEL BLUMENTHAL
10:45:00 TRACK 2 | Towards Data Driven Medicine: Europe Shows the Way JURGI CAMBLONG
11:00:00 TRACK 2 | Discovery in Millions of Genomes
11:00:00 TRACK 1 | Signature: Designed to Find the Right Patient AUGUST SALVADO
11:00:00 TRACK 4 | Innovative Advances in Non-Invasive Prenatal Testing Gautam Kollu
11:15:00 TRACK 1 | Panel
11:15:00 TRACK 2 | Panel
11:15:00 TRACK 4 | Mathias Ehrich
11:25:00 TRACK 2 | Consumer Genomics
11:30:00 TRACK 4 | CCFNA: Improving Prenatal Screening & Beyond LEE SHULMAN
11:30:00 TRACK 2 | Helix: A New Approach to Consumer Genomics
11:30:00 TRACK 1 | CATHERINE POLIZZI, MICHAEL SHUSTER
11:45:00 TRACK 2 | TBA
11:45:00 TRACK 4 | Panel
12:00:00 TRACK 1 | Q&A
12:00:00 TRACK 4 | Lunch, Exhibition & Networking
12:00:00 TRACK 2 | Lunch, Exhibition & Networking
12:15:00 TRACK 1 | Lunch, Exhibition & Networking
12:55:00 TRACK 4 | Carrier and Hereditary Disease Testing
12:55:00 TRACK 2 | Expediting Genomics into the Clinic
12:55:00 TRACK 1 | Expansion of Non-Invasive Prenatal Testing
13:00:00 TRACK 4 | OS-Seq Boosting Genetic Diagnostics TERO-PEKKA ALASTALO
13:00:00 TRACK 1 | Opening by session chair Susan Gross
13:00:00 TRACK 2 | Opening words by session chair Lincoln Nadauld
13:15:00 TRACK 2 | Go Big or Go Home SHERRI Z. MILLIS
13:15:00 TRACK 4 | RAMJI SRINIVASAN
13:15:00 TRACK 1 | Non-invasive Testing for Low-risk Women PETER BENN
13:30:00 TRACK 4 |
13:30:00 TRACK 2 | Implementing a Clinical Cancer Genomics Program James M. Ford
13:45:00 TRACK 2 | Panel
13:45:00 TRACK 4 | RUTH LATHI
13:45:00 TRACK 1 | Panel
13:55:00 TRACK 1 | The Microbiome- A Modifiable Biomarker?
13:55:00 TRACK 2 | Producing Clinical Actionable Reports
14:00:00 TRACK 1 | Opening words by session chair AMI S. BHATT
14:00:00 TRACK 2 | Scaling & Enhancing PM Reporting SEAN SIGMON
14:00:00 TRACK 4 | Panel
14:10:00 TRACK 4 | Obesity & Diabetes
14:15:00 TRACK 1 | Exploring the Microbiome for Novel Therapeutics
14:15:00 TRACK 4 | Personalised Healthcare in Metabolic Disease RUTH MARCH
14:15:00 TRACK 2 | Big Data to Actionable Reports DON RULE
14:30:00 TRACK 4 | Genes & Environment in Metabolic Disease ROBERT H. LUSTIG
14:30:00 TRACK 1 | Microbiome Therapeutics in The Age of Personalized DNA Sequence David Cook
14:30:00 TRACK 2 | Bootstrapping Clinically Actionable Reports
14:45:00 TRACK 1 | Panel
14:45:00 TRACK 2 | Panel
14:45:00 TRACK 4 | Panel
15:00:00 TRACK 4 | Break, Exhibition & Networking
15:00:00 TRACK 1 | Break, Exhibition & Networking
15:00:00 TRACK 2 | Break, Exhibition & Networking
15:25:00 TRACK 1 | Changing the Point Of Care Setting
15:30:00 TRACK 1 | Changing the Point-of-Care Setting for Precision Medicine in Infectious Diseases CHARLES CHIU
15:30:00 TRACK 2 | Closing
15:30:00 TRACK 4 | Closing
16:00:00 TRACK 1 | Closing
3D Tissue Models
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.